Literature DB >> 7785476

Pretreatment dropout as a function of treatment delay and client variables.

D S Festinger1, R J Lamb, M R Kountz, K C Kirby, D Marlowe.   

Abstract

Utilizing a retrospective analysis we examined factors correlated with preintake dropout in patients phoning to make intake appointments for cocaine treatment. Inquiries of 235 individuals calling our outpatient cocaine treatment program over a 7-month period were analyzed for relationships between patient age and gender; residence in the city where the program is located; marital status; referral source; reported problems with alcohol, marijuana, and heroin; reported last use of cocaine or other illicit stimulants; assigned counselor gender; person who made the appointment; days to the intake appointment; and attending the scheduled intake session. Only days to appointment was significantly (Wald = 12.4587, df = 1, p < .05 and chi 2 = 17.7, df = 8, p < .05) correlated with attending the scheduled intake session. Appointments scheduled the same day differed significantly (chi 2 = 4.3, n = 235, df = 1, p < .05) from appointments scheduled later. This suggests that client and situational variables are not significantly related to initial attendance and enhances the significance of systemic variables that are under a clinic's control, such as appointment delay. The results indicate that the longer the delay between the initial phone contact and the scheduled appointment, the less likely a client is to attend an appointment. Further, they suggest that the greatest decrease in initial attendance occurs in the first 24 hours following the phone inquiry. Taking a "microscopic" look at the appointment delay variable is valuable in understanding and addressing preintake dropout.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785476     DOI: 10.1016/0306-4603(94)00052-z

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  30 in total

1.  Gaps in the Substance Use Disorder Treatment Referral Process: Provider Perceptions.

Authors:  Claire E Blevins; Nishi Rawat; Michael D Stein
Journal:  J Addict Med       Date:  2018 Jul/Aug       Impact factor: 3.702

2.  Treatment barriers identified by substance abusers assessed at a centralized intake unit.

Authors:  Richard C Rapp; Jiangmin Xu; Carey A Carr; D Tim Lane; Jichuan Wang; Robert Carlson
Journal:  J Subst Abuse Treat       Date:  2006-04

3.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

4.  Participation in treatment and Alcoholics Anonymous: a 16-year follow-up of initially untreated individuals.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  J Clin Psychol       Date:  2006-06

5.  Access to drug abuse treatment under Treatment on Demand policy in San Francisco.

Authors:  James L Sorensen; Joseph Guydish; Pamela Zilavy; Thomas B Davis; Alice Gleghorn; Marvin Jacoby; Clare Sears
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

6.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

7.  Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2006-09

8.  The accelerated intake: a method for increasing initial attendance to outpatient cocaine treatment.

Authors:  D S Festinger; R J Lamb; K C Kirby; D B Marlowe
Journal:  J Appl Behav Anal       Date:  1996

9.  Incentives in a public addiction treatment system: Effects on waiting time and selection.

Authors:  Maureen T Stewart; Sharon Reif; Beth Dana; AnMarie Nguyen; Maria Torres; Margot T Davis; Grant Ritter; Dominic Hodgkin; Constance M Horgan
Journal:  J Subst Abuse Treat       Date:  2018-09-07

10.  Efficacy of treatment in an opioid -dependent population group using the Maudsley Addiction Profile (MAP) tool.

Authors:  Ruth Collins; Bob Boggs; Noel Taggart; Martin Kelly; Aileen Drillington; Ivy Swanton; Diane Patterson
Journal:  Ulster Med J       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.